SMS Pharmaceuticals, engaged in the manufacture of active pharmaceutical ingredients and drug intermediates, announced that the company will consider stock split i.e. sub-division of equity shares as per ratio finalized by the board on October 9, 2015.

SMS Pharmaceuticals is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities.

The company started off as a single facility and single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments.

Shares of the company declined Rs 1, or 0.15%, to trade at Rs 650.00. The total volume of shares traded was 1,768 at the BSE (12.24 p.m., Thursday).